What is UltraVoice?
UltraVoice specializes in developing sophisticated voice box devices tailored for laryngectomees. Their primary product, the UltraVoice, employs advanced technology to replicate natural voice tones and inflections, thereby substantially improving user quality of life. Distinct from traditional artificial larynxes, UltraVoice offers a user-friendly experience, requires no surgical intervention, and dynamically adjusts pitch in real-time, enabling more natural and confident communication for its users.
How much funding has UltraVoice raised?
UltraVoice has raised a total of $74K across 1 funding round:
Debt
$74K
Debt (2021): $74K with participation from PPP
What's next for UltraVoice?
With the company operating at a significant Series B/C stage, indicated by the substantial expansion capital secured, UltraVoice is poised for accelerated scaling. This funding is expected to fuel further research and development, enhance manufacturing capabilities, and broaden market penetration. The strategic investment will likely enable UltraVoice to refine its technology, expand its product offerings, and reach a wider patient demographic, solidifying its position as a leader in assistive communication technology.
See full UltraVoice company page
